Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

6.15
+0.620011.21%
Post-market: 6.150.0001+0.00%17:48 EDT
Volume:1.52M
Turnover:9.21M
Market Cap:333.23M
PE:-1.71
High:6.36
Open:5.73
Low:5.63
Close:5.53
Loading ...

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic

GlobeNewswire
·
09 Oct 2024

Emergent BioSolutions Grants CFO Stock for Contributions

TIPRANKS
·
04 Oct 2024

Emergent Enters New $100 Million Revolving Credit Agreement

MT Newswires Live
·
02 Oct 2024

Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility

THOMSON REUTERS
·
02 Oct 2024

Emergent BioSolutions Inc - New Credit Agreement Provides up to $100 Million Revolving Loan

THOMSON REUTERS
·
02 Oct 2024

Emergent BioSolutions- as of Sept 30, Has $150 Mln Cash Balance, $100 Mln Undrawn Access

THOMSON REUTERS
·
02 Oct 2024

Press Release: Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility

Dow Jones
·
02 Oct 2024

Emergent BioSolutions Shares Rise on U.S. Smallpox-Treatment Order

Dow Jones
·
27 Sep 2024

Emergent Biosolutions Awarded Contract Options Worth $67.4 Million

MT Newswires Live
·
26 Sep 2024

BRIEF-Emergent Biosolutions Announces The Execution Of Contract Options Valued At $67.4 Million To Procure Additional Tembexa

Reuters
·
26 Sep 2024

Emergent BioSolutions announces execution of contract options valued at $67.4M

TIPRANKS
·
26 Sep 2024

Emergent BioSolutions Inc - Funding Committed Through 2027 for Tembexa Supply

THOMSON REUTERS
·
26 Sep 2024

Emergent BioSolutions Inc - Contract Has Maximum Potential Value of $568 Million

THOMSON REUTERS
·
26 Sep 2024

Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional Tembexa® (Brincidofovir) to Support National Preparedness Efforts

THOMSON REUTERS
·
26 Sep 2024

Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts

GlobeNewswire
·
26 Sep 2024

Shares of Emergent BioSolutions up 5.9% on Disclosing $400 Mln in Orders Through 2025

THOMSON REUTERS
·
25 Sep 2024